These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7943014)

  • 1. Relationship of expansion of CGG repeats and X-inactivation with expression of fra(X)(q27.3) in heterozygotes.
    Mingroni-Netto RC; Fernandes JG; Vianna-Morgante AM
    Am J Med Genet; 1994 Jul; 51(4):443-6. PubMed ID: 7943014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetry of methylation with FMR-1 full mutation in two 45,X/46,XX mosaic females associated with normal intellect.
    Shapiro LR; Simensen RJ; Wilmot PL; Fisch GS; Vibert BK; Fenwick RG; Tarleton J; Phelan MC
    Am J Med Genet; 1994 Jul; 51(4):507-8. PubMed ID: 7943030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling methylation and IQ scores in fragile X females and mosaic males.
    Kolehmainen K; Karant Y
    Am J Med Genet; 1994 Jul; 51(4):328-38. PubMed ID: 7942995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Unstable DNA sequence and methylation in fragile X syndrome].
    Fu SD; Shen Y; Fan Y
    Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):611-4, 646-7. PubMed ID: 7842338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression.
    Hagerman RJ; Hull CE; Safanda JF; Carpenter I; Staley LW; O'Connor RA; Seydel C; Mazzocco MM; Snow K; Thibodeau SN
    Am J Med Genet; 1994 Jul; 51(4):298-308. PubMed ID: 7942991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular-neurobehavioral associations in females with the fragile X full mutation.
    Abrams MT; Reiss AL; Freund LS; Baumgardner TL; Chase GA; Denckla MB
    Am J Med Genet; 1994 Jul; 51(4):317-27. PubMed ID: 7942994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X syndrome.
    Laxova R
    Adv Pediatr; 1994; 41():305-42. PubMed ID: 7992687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X induction systems in CVS cultures: effect on cytogenetic, PCR, and genomic Southern Blot DNA analyses of the FMR-1 gene.
    Jenkins EC; Morys I; Henderson J; Genovese M; Carter M; Li SY; Houck GE; Ding X; Stark-Houck SL; Dobkin CS
    Am J Med Genet; 1994 Jul; 51(4):436-42. PubMed ID: 7943013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assay for X inactivation based on differential methylation at the fragile X locus, FMR1.
    Carrel L; Willard HF
    Am J Med Genet; 1996 Jul; 64(1):27-30. PubMed ID: 8826444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of FMR-1 gene expression by RT-PCR].
    Zheng L; Fan Y; Huang T; Zhu N; Shen Y; Wu G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Dec; 17(6):407-11. PubMed ID: 9208564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene.
    Hansen RS; Gartler SM; Scott CR; Chen SH; Laird CD
    Hum Mol Genet; 1992 Nov; 1(8):571-8. PubMed ID: 1301165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosaicism in fragile X affected males.
    Nolin SL; Glicksman A; Houck GE; Brown WT; Dobkin CS
    Am J Med Genet; 1994 Jul; 51(4):509-12. PubMed ID: 7943031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate and acetyl-carnitine inhibit the cytogenetic expression of the fragile X in vitro.
    Pomponi MG; Neri G
    Am J Med Genet; 1994 Jul; 51(4):447-50. PubMed ID: 7943015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The number of CGG repeats of the FMR1 locus in premutated and fully mutated heterozygotes and their offspring: implications for the origin of mosaicism.
    Mingroni-Netto RC; Haddad LA; Vianna-Morgante AM
    Am J Med Genet; 1996 Aug; 64(2):270-3. PubMed ID: 8844063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length.
    Smits A; Smeets D; Hamel B; Dreesen J; de Haan A; van Oost B
    Am J Med Genet; 1994 Jul; 51(4):497-500. PubMed ID: 7943027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reinvestigation of thirty three fragile(X) families using probe StB12.3.
    Macpherson J; Harvey J; Curtis G; Webb T; Heitz D; Rousseau F; Jacobs P
    Am J Med Genet; 1992 Jul; 43(5):905-12. PubMed ID: 1642285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of the absence of FMR1 expression in full mutation chorionic villi.
    Willemsen R; Bontekoe CJ; Severijnen LA; Oostra BA
    Hum Genet; 2002 Jun; 110(6):601-5. PubMed ID: 12107447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene.
    Steyaert J; Borghgraef M; Legius E; Fryns JP
    Am J Med Genet; 1996 Aug; 64(2):274-7. PubMed ID: 8844064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.